Contact this trialFirst, we need to learn more about you.
Thiazolidinedione
Rosiglitazone for Prediabetes-Related Coronary Artery Disease
Recruiting3 awardsPhase 4
Denver, Colorado
This trial will study the effects of rosiglitazone on exercise tolerance, coronary artery calcification, and diabetes indicators in subjects with impaired glucose tolerance.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.